Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 16/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7017973 | 0.75 | CXCR2 (0.39) | HSD11B1 | |
| SCHEMBL7022717 | 0.75 | MTNR1A (0.70) | MTNR1AMTNR1BNQO2HTR2C | |
| SCHEMBL7013756 | 0.75 | ENPP3 (0.39) | MTNR1AMTNR1BSMN1; SMN2 | |
| SCHEMBL7203743 | 0.74 | MTNR1A (1.00) | MTNR1AMTNR1B | |
| SCHEMBL3949444 | 0.73 | MTNR1A (0.71) | MTNR1AMTNR1BNQO2HTR2CHTR2B | |
| SCHEMBL7201899 | 0.71 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2HTR2CHTR2B | |
| SCHEMBL7019670 | 0.71 | MTNR1A (0.70) | MTNR1AMTNR1BHTR2CHTR2B | |
| SCHEMBL7024310 | 0.71 | MTNR1A (0.70) | MTNR1AMTNR1BNQO2HTR2B | |
| SCHEMBL8054353 | 0.69 | MTNR1A (0.75) | MTNR1AMTNR1BHTR2CHTR2B | |
| SCHEMBL7023127 | 0.69 | MTNR1A (0.61) | MTNR1AMTNR1BNQO2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1057826-B1 | Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them | SERVIER LAB (FR) | 2003-04-16 | — | — | EP | disclosed |
| US-6310074-B1 | TREATING MELATONINERGIC DISORDERS | ADIR ET COMPAGNIE (FR) | 2001-10-30 | — | — | US | disclosed |
| EP-1057826-A1 | Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 2000-12-06 | — | — | EP | disclosed |